Results · Apr-Jun 2026 · filed 13 Aug 2026
Bandaram Pharma Packtech Q1 FY27 results
Sales grew 196% to ₹24 crore from ₹8.1 crore in Apr-Jun 2025.
Operating profit grew 145% to ₹1.5 crore, an operating margin of 6.4% (down 1.3 points from a year ago).
Net profit grew 2671% to ₹0.68 crore from ₹0.02 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −9%, net profit +543%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 24.0 | 8.1 | +196% |
| Operating profit (EBITDA) | 1.5 | 0.6 | +145% |
| Operating margin | 6.4% | 7.8% | −1.3 pts |
| Net profit | 0.7 | 0.0 | +2671% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Change in Management
- 13 Aug 2026Un-Audited Financial Results (Standalone & Consolidated) For The Quater Ended 30.06.2026
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.